AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 271 min read$BMRA

Chin Eric purchased $10K of BMRA

Chin Eric purchased 6,250 shares of BIOMERICA INC (BMRA) at $1.60 on 2026-08-26.

Original reporting
SEC EDGAR · Chin Eric
Published Aug 27, 2026, 9:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 10:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$BMRA
Neutral
high confidence
Mentioned
$BMRA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BMRANeutralLow
01

Why it matters

The purchase is modest and unlikely to move the stock significantly.

02

Market read

Low relevance; routine insider transaction.

03

What to watch

Potential upcoming corporate actions or news not yet disclosed.

Relevance 4/10Novelty 2/10Timing: filed today

Background

Form 4 filings disclose insider transactions; director purchases are monitored for signals.

Company-level read

Ticker impact

$BMRANeutralHigh confidence
Context

Director Chin Eric bought 6,250 shares of Biomerca Inc for $10,000, increasing his stake to 38,750 shares.

Expected impact

Minimal upward pressure, likely negligible.

Evidence & confidence

The transaction size is small relative to typical market volume and does not signal material change.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Even small insider buys can precede larger moves; monitor for follow‑on activity.

Key entities

  • Company
    Biomerca Inc

    Biotech company issuing the Form 4.

  • Insider
    Chin Eric

    Director of Biomerca Inc who made the purchase.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BMRA insider trading history →

Related articles

MAY 28
$BMRAMedAI 9/10

Biomerica Wins $1.75M Contract to Develop Diagnostic Tests

Biomerica Inc. said it was selected for a $1.75 million master services agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The three-year work will be performed at Biomerica’s Irvine facility, according to the company. Biomerica said the initial fees provide near-term revenue visibility. Shares fell 2.2% to $2.40.

ocbj.com3 min